Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NOVONIX Ltd Capital/Financing Update 2021

Mar 25, 2021

33557_rns_2021-03-25_8e723b00-6dbd-4ac8-a8fd-39a7682e00df.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

NOVONIX Limited

(ACN 157 690 830)

Notice of Extraordinary General Meeting

Notice is given that an Extraordinary General Meeting of shareholders of NOVONIX Limited (ACN 157 690 830) (the Company ) will be held on 27 April 2021 at 11:00am (AEST) at Allens, Level 26, 480 Queen Street, Brisbane (the Meeting ).

Important: The resolutions set out in this Notice should be read together with the accompanying Explanatory Memorandum.

Agenda

Resolution 1 – Issue of Shares to a related party, Mr Trevor St Baker AO (or his

nominees), under the Conditional Placement

To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution:

'That for the purposes of Listing Rule 10.11 and for all other purposes, Shareholders approve the issue of up to 4,137,931 new Shares in the capital of the Company at an issue price of $2.90 per Share to Mr Trevor St Baker AO (or his nominees), on the terms and conditions set out in the Explanatory Memorandum.'

Voting exclusion

The Company will disregard any votes cast on this resolution by certain persons. Details of the applicable voting exclusions are set out in the 'Voting exclusions' section of the Notes to this Notice.

Resolution 2 – Issue of Shares to a related party, Mr Andrew N Liveris AO (or his nominees), under the Conditional Placement

To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution:

'That for the purposes of Listing Rule 10.11 and for all other purposes, Shareholders approve the issue of up to 1,034,483 new Shares in the capital of the Company at an issue price of $2.90 per Share to Mr Andrew N Liveris AO (or his nominees), on the terms and conditions set out in the Explanatory Memorandum.'

Voting exclusion

The Company will disregard any votes cast on this resolution by certain persons. Details of the applicable voting exclusions are set out in the 'Voting exclusions' section of the Notes to this Notice.

Resolution 3 – Issue of Shares to a related party, Admiral Robert J Natter (or his nominees), under the Conditional Placement

To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution:

'That for the purposes of Listing Rule 10.11 and for all other purposes, Shareholders approve the issue of up to 431,034 new Shares in the capital of the Company at an issue price of $2.90 per Share to Admiral Robert J Natter (or his nominees), on the terms and conditions set out in the Explanatory Memorandum.'

Voting exclusion

The Company will disregard any votes cast on this resolution by certain persons. Details of the applicable voting exclusions are set out in the 'Voting exclusions' section of the Notes to this Notice.

page 1

NOVONIX Limited (ACN 157 690 830)

Resolution 4 – Issue of Shares to a related party, Mr Robert Cooper (or his nominees), under the Conditional Placement

To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution:

'That for the purposes of Listing Rule 10.11 and for all other purposes, Shareholders approve the issue of up to 68,966 new Shares in the capital of the Company at an issue price of $2.90 per Share to Mr Robert Cooper (or his nominees), on the terms and conditions set out in the Explanatory Memorandum.'

Voting exclusion

The Company will disregard any votes cast on this resolution by certain persons. Details of the applicable voting exclusions are set out in the 'Voting exclusions' section of the Notes to this Notice.

The attached Explanatory Memorandum is incorporated into and forms part of this Notice. Detailed explanations of the background and reasons for the proposed resolutions are set out in the Explanatory Memorandum.

By order of the Board of Directors

Suzanne Yeates Company Secretary

26 March 2021

Dated

page 2

NOVONIX Limited (ACN 157 690 830)

Notes

Eligibility to Vote

Regulation 7.11.37 of the Corporations Regulations 2001 (Cth) permits the Company to specify a time, not more than 48 hours before a general meeting, at which a 'snap-shot' of Shareholders will be taken for the purposes of determining Shareholder entitlements to vote at the Meeting.

The Board has determined that the Shareholders of the Company at 11:00am (AEST) on 25 April 2021 will be taken to be holders of Shares for the purposes of the Meeting and accordingly, will be entitled to attend and vote at the Meeting.

Voting by Proxy

An eligible Shareholder can vote in person at the Meeting or appoint a proxy or, where a Shareholder is entitled to two or more votes, two proxies. Where two proxies are appointed, a Shareholder may specify the number or proportion of votes to be exercised by each proxy appointed. If no number or proportion of votes is specified, each proxy appointed will be taken to exercise half of that Shareholder’s votes (disregarding fractions).

An appointed proxy need not themselves be a Shareholder.

To be valid, the appointment of a proxy (made using a properly completed and executed Proxy Form) must be received by the Company no later than 48 hours before the commencement of the Meeting (i.e. 11am on Sunday, 25 April 2021).

Proxy Forms can be submitted in four ways

  • Online by visiting the Company's registry's website ( www.linkmarketservices.com.au ). Please follow the prompts and have your SRN or HIN available

  • By mail to:

NOVONIX Limited

c/- Link Market Services Limited

Locked Bag A14

Sydney South NSW 1235 Australia

  • By facsimile to +61 2 9287 0309

  • By hand to:

Link Market Services Limited

  • 1A Homebush Bay Drive

Rhodes NSW 2138

Instructions on how to complete the Proxy Form are on the reverse of the Proxy Form attached to this Notice.

If a Proxy Form is signed by an attorney, a Shareholder must also send in the original or a certified copy of the power of attorney or other authority under which the Proxy Form is signed.

Undirected Proxies

The Chair intends to vote undirected proxy votes in favour of all resolutions (subject to the voting exclusions below).

page 3

NOVONIX Limited

(ACN 157 690 830)

Voting by Corporate Representative

A Shareholder or proxy which is a corporation and entitled to attend and vote at the Meeting may appoint an individual to act as its corporate representative to vote at the Meeting. The appointment must comply with section 250D of the Corporations Act. The representative should bring to the Meeting evidence of his or her appointment unless it has previously been provided to the Company's registry.

Voting by Attorney

A Shareholder entitled to attend and vote at the Meeting is entitled to appoint an attorney to attend and vote at the Meeting on the Shareholder's behalf. An attorney need not themselves be a Shareholder.

The power of attorney appointing the attorney must be signed and specify the name of each of the Shareholder, the Company and the attorney, and also specify the meeting(s) at which the appointment may be used. The appointment may be a standing one.

To be effective, the power of attorney must also be returned in the same manner, and by the same time, as specified for Proxy Forms.

Voting Exclusions

The Corporations Act and the ASX Listing Rules require that certain persons must not vote in particular ways, and the Company must disregard particular votes cast by or on behalf of certain persons, on each of the Resolutions to be considered at the Extraordinary General Meeting. These voting exclusions are described below.

Under Listing Rule 14.11, the Company will disregard any votes cast in favour of a Resolution by or on behalf of:

  • (a) the below named person or class of persons excluded from voting; or

  • (b) an associate of that person or those persons:

Resolution Persons excluded from voting
Resolution 1 – Issue of Shares to
a related party, Mr Trevor St Baker
AO (or his nominees), under the
Conditional Placement
Mr Trever St Baker AO (and his nominee/s) and any other person
who will obtain a material benefit as a result of the issue of the
securities (except a benefit solely by reason of being a holder of
ordinary securities in the Company).
Resolution 2 – Issue of Shares to
a related party, Mr Andrew N
Liveris AO (or his nominees),
under the Conditional Placement
Mr Andrew N Liveris AO (and his nominee/s) and any other
person who will obtain a material benefit as a result of the issue
of the securities (except a benefit solely by reason of being a
holder of ordinary securities in the Company).
Resolution 3 – Issue of Shares to
a related party, Admiral Robert J
Natter (or his nominees), under
the Conditional Placement
Admiral Robert J Natter (and his nominee/s) and any other
person who will obtain a material benefit as a result of the issue
of the securities (except a benefit solely by reason of being a
holder of ordinary securities in the Company).
Resolution 4 – Issue of Shares to
a related party, Mr Robert Cooper
(or his nominees), under the
Conditional Placement
Mr Robert Cooper (and his nominee/s) and any other person who
will obtain a material benefit as a result of the issue of the
securities (except a benefit solely by reason of being a holder of
ordinary securities in the Company).

However, this does not apply to a vote cast in favour of a Resolution by:

page 4

NOVONIX Limited

(ACN 157 690 830)

  • (a) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with the directions given to the proxy or attorney to vote on the Resolution in that way; or

  • (b) the Chair as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or

  • (c) a holder acting solely as nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

  • (i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolution; and

  • (ii) the holder votes on the Resolution in accordance with directions given by the beneficiary to the holder to vote in that way.

The Company will also apply these voting exclusions to persons appointed as attorney by a Shareholder to attend and vote at the Extraordinary General Meeting under a power of attorney, as if they were appointed as a proxy.

Resolutions

All items of business involving a vote by Shareholders require Ordinary Resolutions, which means that, to be passed, the item needs the approval of a simple majority of the votes cast by Shareholders entitled to vote on the Resolution.

page 5

NOVONIX Limited

(ACN 157 690 830)

Explanatory Memorandum

This Explanatory Memorandum forms part of the notice convening the Extraordinary General Meeting of NOVONIX Limited to be held at 11:00am (AEST) at Allens, Level 26, 480 Queen Street, Brisbane.

Background to the Extraordinary General Meeting and Resolutions

Capital Raising

On 25 February 2021, the Company announced that it will undertake a capital raising to raise approximately $146 million, comprising:

  • a fully underwritten placement to institutional and sophisticated investors to raise approximately $115 million within the Company's current placement capacity under ASX Listing Rule 7.1 ( Institutional Placement ), through the issue of 39.7 million new Shares (representing approximately 11.3% of the total Shares of the Company prior to the issue);

  • a non-underwritten share purchase plan targeting approximately $15 million ( SPP ); and

  • subject to obtaining Shareholder approval and completion of the Institutional Placement and SPP, a non-underwritten placement of new Shares, at the same issue price per new Share as the Institutional Placement, to each of the following Directors (or entities associated with them) to raise approximately $16.45 million in aggregate, with the value of each Director's individual placement commitment being:

  • Mr Trevor St Baker AO – $12 million;

  • Mr Andrew N Liveris AO – $3 million;

  • Admiral Robert J Natter – $1.25 million; and

  • Mr Robert Cooper – $200,000,

(each a Conditional Placement , and together the Conditional Placements ).

On 26 February 2021, the Company announced the successful completion of the Institutional Placement, which raised $115 million at an offer price of $2.90 per new Share.

Conditional Placements

On 4 March 2021, the Company announced the deferral of the SPP until the Company's Share price stabilises. However the Company subsequently confirmed that the Conditional Placements will still proceed, and confirmed that they are no longer conditional on completion of the SPP. In this announcement it was also noted that the Directors confirmed that they remain committed to subscribing for shares under the Conditional Placements. Accordingly, the Conditional Placements are now only conditional on Shareholder approval being obtained at the Meeting.

The Resolutions seek shareholder approval for the purposes of Listing Rule 10.11 to approve the issue of Shares under the Conditional Placements to Mr Trevor St Baker AO, Mr Andrew N Liveris AO, Admiral Robert J Natter and Mr Robert Cooper or their respective nominees (which will be entities that are associated with each of the respective Directors).

Following completion of the Conditional Placements, each Director (or entities associated with each Director) will hold the following interests in the total issued Share capital of the Company:[1]

  • Mr Trevor St Baker AO – 16.18%; and

  • Mr Andrew N Liveris AO – 1.93%;

1 Assuming that completion of the Conditional Placements occurs before completion of the SPP, if and when the SPP proceeds

page 6

NOVONIX Limited

(ACN 157 690 830)

  • Admiral Robert J Natter – 0.51%; and

  • Mr Robert Cooper – 0.18%.

Use of funds

Net proceeds from the Conditional Placements, combined with the Institutional Placement, will fund expansion capex and working capital to scale NOVONIX Anode Materials production to 10,000tpa under an exclusive technology alliance announced in December with US-based thermal processing solutions expert, Harper International Corporation. This will include new manufacturing site expansion, along with infrastructure and equipment being commissioned over the next 24 months, as well as working capital associated with increased production levels.

Subject to prevailing market conditions, the Company's management expects that 2,000tpa production levels will provide a basis to secure multi-year contracts and support subsequent plant expansion with access to debt funding.

In addition to scaling NOVONIX Anode Materials to 10,000tpa, net proceeds will fund a Research and Development (R&D) program for NOVONIX Cathode Materials (based on the proprietary DPMG technology), and also support the Company’s global growth initiatives including organic expansion, partnerships and licensing.

Listing Rules

Broadly speaking, Listing Rule 7.1 limits the number of equity securities a company can issue in a 12 month period to 15% of its issued share capital, except for certain issues, including where first approved by shareholders.

Listing Rule 10.11 provides that unless one of the exceptions in Listing Rule 10.12 applies, a listed company must not issue or agree to issue equity securities to a related party unless it obtains the approval of its shareholders. Securities issued with shareholder approval under Listing Rule 10.11 are not included in the 15% capacity under Listing Rule 7.1.

The issues under the Conditional Placements each fall within Listing Rule 10.11.1, and do not fall within any of the exceptions in Listing Rule 10.12. Each Conditional Placement therefore requires the approval of Shareholders under Listing Rule 10.11.

Corporations Act

Chapter 2E of the Corporations Act prohibits a public company from giving a financial benefit to a related party of the company unless either:

  • (a) the giving of the financial benefit falls within one of the exceptions to the provision; or

  • (b) prior shareholder approval is obtained to the giving of the financial benefit.

Related party is widely defined under the Corporations Act and includes directors of a company. Financial benefit is defined broadly and includes benefits from the public company’s subsidiaries. It is necessary to look at the economic and commercial substance and the effect of the transaction in determining the financial benefit. The Corporations Act requires that any consideration that is given is disregarded, even if the consideration is adequate.

As the issue price under the Conditional Placements is the same as the issue price under the Institutional Placement, the Board (with Mr Trevor St Baker AO, Mr Andrew N Liveris AO, Admiral Robert J Natter and Mr Robert Cooper excluded from voting due to their perceived personal interests in the matter), considers the proposed issues under the Conditional Placements to be reasonable in the circumstances as if the Company and each Director were dealing at arm’s length so that Shareholder approval is not required under Chapter 2E of the Corporations Act.

page 7

NOVONIX Limited (ACN 157 690 830)

Resolutions

1 Resolution 1 – Issue of Shares to Mr Trevor St Baker AO (or his nominees) under the Conditional Placement

Resolution 1 seeks Shareholder approval under Listing Rule 10.11 for the issue of Shares to Mr Trevor St Baker AO, a Director, or his nominees.

If Resolution 1 is passed, the Company can proceed with the issue. Approval under Listing Rule 10.11 means that Shareholder approval is not required under Listing Rule 7.1 and the issue will not reduce the Company's 15% placement capacity under Listing Rule 7.1.

If Resolution 1 is not passed, the Company will not be able to proceed with the issue. If this happens, the Company may not be able to apply the expected proceeds of this Conditional Placement as intended and in accordance with the 'Use of funds' section of this Explanatory Memorandum, which may affect the prospects of the Company.

For the purposes of Listing Rule 10.13, the following information is provided for the issue of Shares under Resolution 1:

  • (a) The person participating in the issue is Mr Trevor St Baker AO, a Director. As a Director, Mr Trevor St Baker AO is a related party and subject to Listing Rule 10.11.1.

  • (b) The number of Shares to be issued is 4,137,931 Shares.

  • (c) The Shares to be issued are fully paid ordinary shares in the capital of the Company, ranking equally with existing fully paid ordinary shares on issue.

  • (d) The Shares will be issued on the date that is 10 Business Days after the date of the Meeting.

  • (e) The Shares will be issued at an issue price of $2.90 per Share.

  • (f) The purpose of the issue is to enable the Company to scale-up anode materials product and fund growth projects. The use of funds is as set out under the 'Use of funds' section of this Explanatory Memorandum.

  • (g) The issue is not intended to remunerate or incentivise any Director.

  • (h) Other than those set out in this Explanatory Memorandum, there are no other material terms in relation to the issue.

  • (i) A voting exclusion statement is included in the Notes to the Notice of Extraordinary General Meeting.

2 Resolution 2 – Issue of Shares to Mr Andrew N Liveris AO (or his nominees) under the Conditional Placement

Resolution 2 seeks Shareholder approval under Listing Rule 10.11 for the issue of Shares to Mr Andrew N Liveris AO, a Director, or his nominees.

If Resolution 2 is passed, the Company can proceed with the issue. Approval under Listing Rule 10.11 means that Shareholder approval is not required under Listing Rule 7.1 and the issue will not reduce the Company's 15% placement capacity under Listing Rule 7.1.

If Resolution 2 is not passed, the Company will not be able to proceed with the issue. If this happens, the Company may not be able to apply the expected proceeds of this Conditional Placement as intended and in accordance with the 'Use of funds' section of this Explanatory Memorandum, which may affect the prospects of the Company.

For the purposes of Listing Rule 10.13, the following information is provided for the issue of Shares under Resolution 2:

page 8

NOVONIX Limited

(ACN 157 690 830)

  • (a) The person participating in the issue is Mr Andrew N Liveris AO, a Director. As a Director, Mr Andrew N Liveris AO is a related party and subject to Listing Rule 10.11.1.

  • (b) The number of Shares to be issued is 1,034,483 Shares.

  • (c) The Shares to be issued are fully paid ordinary shares in the capital of the Company, ranking equally with existing fully paid ordinary shares on issue.

  • (d) The Shares will be issued on the date that is 10 Business Days after the date of the Meeting.

  • (e) The Shares will be issued at an issue price of $2.90 per Share.

  • (f) The purpose of the issue is to enable the Company to scale-up anode materials product and fund growth projects. The use of funds is as set out under the 'Use of funds' section of this Explanatory Memorandum.

  • (g) The issue is not intended to remunerate or incentivise any Director.

  • (h) Other than those set out in this Explanatory Memorandum, there are no other material terms in relation to the issue.

  • (i) A voting exclusion statement is included in the Notes to the Notice of Extraordinary General Meeting.

3 Resolution 3 – Issue of Shares to Admiral Robert J Natter (or his nominees) under the Conditional Placement

Resolution 3 seeks Shareholder approval under Listing Rule 10.11 for the issue of Shares to Admiral Robert J Natter, a Director, or his nominees.

If Resolution 3 is passed, the Company can proceed with the issue. Approval under Listing Rule 10.11 means that Shareholder approval is not required under Listing Rule 7.1 and the issue will not reduce the Company's 15% placement capacity under Listing Rule 7.1.

If Resolution 3 is not passed, the Company will not be able to proceed with the issue. If this happens, the Company may not be able to apply the expected proceeds of this Conditional Placement as intended and in accordance with the 'Use of funds' section of this Explanatory Memorandum, which may affect the prospects of the Company.

For the purposes of Listing Rule 10.13, the following information is provided for the issue of Shares under Resolution 3:

  • (a) The person participating in the issue is Admiral Robert J Natter, a Director. As a Director, Admiral Robert J Natter is a related party and subject to Listing Rule 10.11.1.

  • (b) The number of Shares to be issued is 431,034 Shares.

  • (c) The Shares to be issued are fully paid ordinary shares in the capital of the Company, ranking equally with existing fully paid ordinary shares on issue.

  • (d) The Shares will be issued on the date that is 10 Business Days after the date of the Meeting.

  • (e) The Shares will be issued at an issue price of $2.90 per Share.

  • (f) The purpose of the issue is to enable the Company to scale-up anode materials product and fund growth projects. The use of funds is as set out under the 'Use of funds' section of this Explanatory Memorandum.

  • (g) The issue is not intended to remunerate or incentivise any Director.

  • (h) Other than those set out in this Explanatory Memorandum, there are no other material terms in relation to the issue.

page 9

NOVONIX Limited

(ACN 157 690 830)

  • (i) A voting exclusion statement is included in the Notes to the Notice of Extraordinary General Meeting.

4 Resolution 4 – Issue of Shares to Mr Robert Cooper (or his nominees) under the Conditional Placement

Resolution 4 seeks Shareholder approval under Listing Rule 10.11 for the issue of Shares to Mr Robert Cooper, a Director, or his nominees.

If Resolution 4 is passed, the Company can proceed with the issue. Approval under Listing Rule 10.11 means that Shareholder approval is not required under Listing Rule 7.1 and the issue will not reduce the Company's 15% placement capacity under Listing Rule 7.1.

If Resolution 4 is not passed, the Company will not be able to proceed with the issue. If this happens, the Company may not be able to apply the expected proceeds of this Conditional Placement as intended and in accordance with the 'Use of funds' section of this Explanatory Memorandum, which may affect the prospects of the Company.

For the purposes of Listing Rule 10.13, the following information is provided for the issue of Shares under Resolution 4:

  • (a) The person participating in the issue is 4Mr Robert Cooper, a Director. As a Director, Mr Robert Cooper is a related party and subject to Listing Rule 10.11.1.

  • (b) The number of Shares to be issued is 68,966 Shares.

  • (c) The Shares to be issued are fully paid ordinary shares in the capital of the Company, ranking equally with existing fully paid ordinary shares on issue.

  • (d) The Shares will be issued on the date that is 10 Business Days after the date of the Meeting.

  • (e) The Shares will be issued at an issue price of $2.90 per Share.

  • (f) The purpose of the issue is to enable the Company to scale-up anode materials product and fund growth projects. The use of funds is as set out under the 'Use of funds' section of this Explanatory Memorandum.

  • (g) The issue is not intended to remunerate or incentivise any Director.

  • (h) Other than those set out in this Explanatory Memorandum, there are no other material terms in relation to the issue.

  • (i) A voting exclusion statement is included in the Notes to the Notice of Extraordinary General Meeting.

Directors' recommendations

1 Resolution 1 – Issue of Shares to Mr Trevor St Baker AO (or his nominees) under a nonunderwritten placement

The Directors (with Mr Trevor St Baker AO abstaining) unanimously recommend that Shareholders vote in favour of Resolution 1 so the proceeds of the issue can be applied as set out under the heading 'Use of funds' in this Explanatory Memorandum.

2 Resolution 2 – Issue of Shares to Mr Andrew N Liveris AO (or his nominees) under a nonunderwritten placement

The Directors (with Mr Andrew N Liveris AO abstaining) unanimously recommend that Shareholders vote in favour of Resolution 2 so the proceeds of the issue can be applied as set out under the heading 'Use of funds' in this Explanatory Memorandum.

page 10

NOVONIX Limited

(ACN 157 690 830)

3 Resolution 3 – Issue of Shares to Admiral Robert J Natter (or his nominees) under a nonunderwritten placement

The Directors (with Admiral Robert J Natter abstaining) unanimously recommend that Shareholders vote in favour of Resolution 3 so the proceeds of the issue can be applied as set out under the heading 'Use of funds' in this Explanatory Memorandum.

4 Resolution 4 – Issue of Shares to Mr Robert Cooper (or his nominees) under a nonunderwritten placement

The Directors (with Mr Robert Cooper abstaining) unanimously recommend that Shareholders vote in favour of Resolution 4 so the proceeds can be applied as set out under the heading 'Use of funds' in this Explanatory Memorandum.

page 11

NOVONIX Limited (ACN 157 690 830)

Glossary

The following terms used in the Notice of Meeting and the Explanatory Memorandum are defined as follows:

$ means Australian dollars.

AEST means Australian Eastern Standard Time.

ASX means the ASX Limited or the securities exchange operated by it (as the case requires).

Board means the board of Directors of the Company from time to time.

Chair means the person appointed Chair of the Meeting.

Company means NOVONIX Limited (ACN 157 690 830).

Conditional Placement has the meaning given to it under the heading 'Background to the Extraordinary General Meeting' in the Explanatory Memorandum.

Corporations Act means the Corporations Act 2001 (Cth) as amended from time to time.

Directors means the directors of the Company from time to time.

Explanatory Memorandum means the explanatory memorandum accompanying this Notice.

Institutional Placement has the meaning given to it under the heading 'Background to the Extraordinary General Meeting' in the Explanatory Memorandum.

Listing Rules means the official listing rules of the ASX as amended from time to time.

Meeting means the Extraordinary General Meeting of Shareholders to be held on 27 April 2021 as convened by the accompanying Notice of Meeting.

Notice of Meeting or Notice means the notice of meeting giving notice to Shareholders of the Meeting, accompanying this Explanatory Memorandum.

Ordinary Resolution means a resolution passed by more than 50% of the votes cast by those entitled to vote on the resolution.

Proxy Form means the proxy form accompanying the Notice of Meeting.

Resolutions means the resolutions set out in the Notice of Meeting.

Shareholder means a registered holder of Shares.

Shares means fully paid ordinary shares in the Company.

SPP has the meaning given to it under the heading 'Background to the Extraordinary General Meeting' in the Explanatory Memorandum.

page 12

NOVONIX Limited ABN 54 157 690 830

==> picture [230 x 52] intentionally omitted <==

LODGE YOUR VOTE

ONLINEwww.linkmarketservices.com.au

BY MAIL  NOVONIX Limited C/- Link Market Services Limited Locked Bag A14 Sydney South NSW 1235 Australia  BY FAX +61 2 9287 0309  BY HAND Link Market Services Limited 1A Homebush Bay Drive, Rhodes NSW 2138  ALL ENQUIRIES TO Telephone: 1300 554 474 Overseas: +61 1300 554 474

PROXY FORM

I/We being a member(s) of NOVONIX Limited and entitled to attend and vote hereby appoint:

APPOINT A PROXY

the Chairman of the OR if you are NOT appointing the Chairman of the Meeting as your proxy, please write the name of the person or Meeting (mark box) body corporate you are appointing as your proxy

or failing the person or body corporate named, or if no person or body corporate is named, the Chairman of the Meeting, as my/our proxy to act on my/our behalf (including to vote in accordance with the following directions or, if no directions have been given and to the extent permitted by the law, as the proxy sees fit) at the Extraordinary General Meeting of the Company to be held at 11:00am (AEST) on Tuesday 27 April 2021 at Allens’ Office, Level 26, 480 Queen Street, Brisbane, QLD 4000 (the Meeting ) and at any postponement or adjournment of the Meeting.

The Chairman of the Meeting intends to vote undirected proxies in favour of each item of business.

VOTING DIRECTIONS

Proxies will only be valid and accepted by the Company if they are signed and received no later than 48 hours before the Meeting. Please read the voting instructions overleaf before marking any boxes with an T

Resolutions

  • 1 Issue of Shares to a related party, Mr Trevor St Baker AO (or his nominees), under the Conditional Placement

  • 2 Issue of Shares to a related party, Mr Andrew N Liveris AO (or his nominees), under the Conditional Placement

  • 3 Issue of Shares to a related party, Admiral Robert J Natter (or his nominees), under the Conditional Placement

  • 4 Issue of Shares to a related party, Mr Robert Cooper (or his nominees), under the Conditional Placement

==> picture [82 x 9] intentionally omitted <==

----- Start of picture text -----

For Against Abstain
----- End of picture text -----*

==> picture [79 x 110] intentionally omitted <==

    • If you mark the Abstain box for a particular Item, you are directing your proxy not to vote on your behalf on a show of hands or on a poll and your votes will not be counted in computing the required majority on a poll.

SIGNATURE OF SHAREHOLDERS – THIS MUST BE COMPLETED

Shareholder 1 (Individual) Joint Shareholder 2 (Individual) Joint Shareholder 3 (Individual) Sole Director and Sole Company Secretary Director/Company Secretary (Delete one) Director

This form should be signed by the shareholder. If a joint holding, either shareholder may sign. If signed by the shareholder’s attorney, the power of attorney must have been previously noted by the registry or a certified copy attached to this form. If executed by a company, the form must be executed in accordance with the company’s constitution and the Corporations Act 2001 (Cth).

NVX PRX2101A

HOW TO COMPLETE THIS SHAREHOLDER PROXY FORM

YOUR NAME AND ADDRESS

This is your name and address as it appears on the Company’s share register. If this information is incorrect, please make the correction on the form. Shareholders sponsored by a broker should advise their broker of any changes. Please note: you cannot change ownership of your shares using this form.

APPOINTMENT OF PROXY

If you wish to appoint the Chairman of the Meeting as your proxy, mark the box in Step 1. If you wish to appoint someone other than the Chairman of the Meeting as your proxy, please write the name of that individual or body corporate in Step 1. A proxy need not be a shareholder of the Company.

DEFAULT TO CHAIRMAN OF THE MEETING

Any directed proxies that are not voted on a poll at the Meeting will default to the Chairman of the Meeting, who is required to vote those proxies as directed. Any undirected proxies that default to the Chairman of the Meeting will be voted according to the instructions set out in this Proxy Form.

VOTES ON ITEMS OF BUSINESS – PROXY APPOINTMENT

You may direct your proxy how to vote by placing a mark in one of the boxes opposite each item of business. All your shares will be voted in accordance with such a direction unless you indicate only a portion of voting rights are to be voted on any item by inserting the percentage or number of shares you wish to vote in the appropriate box or boxes. If you do not mark any of the boxes on the items of business, your proxy may vote as he or she chooses. If you mark more than one box on an item your vote on that item will be invalid.

APPOINTMENT OF A SECOND PROXY

You are entitled to appoint up to two persons as proxies to attend the Meeting and vote on a poll. If you wish to appoint a second proxy, an additional Proxy Form may be obtained by telephoning the Company’s share registry or you may copy this form and return them both together.

LODGEMENT OF A PROXY FORM

This Proxy Form (and any Power of Attorney under which it is signed) must be received at an address given below by 11:00am (AEST) on Sunday, 25 April 2021, being not later than 48 hours before the commencement of the Meeting. Any Proxy Form received after that time will not be valid for the scheduled Meeting.

Proxy Forms may be lodged using the reply paid envelope or:

ONLINE

www.linkmarketservices.com.au

Login to the Link website using the holding details as shown on the Proxy Form. Select ‘Voting’ and follow the prompts to lodge your vote. To use the online lodgement facility, shareholders will need their “Holder Identifier” - Securityholder Reference Number (SRN) or Holder Identification Number (HIN).

BY MAIL

NOVONIX Limited

C/- Link Market Services Limited

Locked Bag A14 Sydney South NSW 1235 Australia

BY FAX

+61 2 9287 0309

BY HAND

delivering it to Link Market Services Limited* 1A Homebush Bay Drive Rhodes NSW 2138

  • During business hours (Monday to Friday, 9:00am–5:00pm)

To appoint a second proxy you must:

  • (a) on each of the first Proxy Form and the second Proxy Form state the percentage of your voting rights or number of shares applicable to that form. If the appointments do not specify the percentage or number of votes that each proxy may exercise, each proxy may exercise half your votes. Fractions of votes will be disregarded; and

  • (b) return both forms together.

SIGNING INSTRUCTIONS

You must sign this form as follows in the spaces provided:

Individual: where the holding is in one name, the holder must sign.

Joint Holding: where the holding is in more than one name, either shareholder may sign.

Power of Attorney: to sign under Power of Attorney, you must lodge the Power of Attorney with the registry. If you have not previously lodged this document for notation, please attach a certified photocopy of the Power of Attorney to this form when you return it.

Companies: where the company has a Sole Director who is also the Sole Company Secretary, this form must be signed by that person. If the company (pursuant to section 204A of the Corporations Act 2001 ) does not have a Company Secretary, a Sole Director can also sign alone. Otherwise this form must be signed by a Director jointly with either another Director or a Company Secretary. Please indicate the office held by signing in the appropriate place.

CORPORATE REPRESENTATIVES

If a representative of the corporation is to attend the Meeting the appropriate “Certificate of Appointment of Corporate Representative” must be produced prior to admission in accordance with the Notice of Meeting. A form of the certificate may be obtained from the Company’s share registry or online at www.linkmarketservices.com.au.

IF YOU WOULD LIKE TO ATTEND AND VOTE AT THE EXTRAORDINARY GENERAL MEETING, PLEASE BRING THIS FORM WITH YOU. THIS WILL ASSIST IN REGISTERING YOUR ATTENDANCE.